Meet STE2P: Advanced action decision for treatment change that is Safe, Timely, Effective, Efficient, and Patient centered

STE2P for Hypertension: optima4BP

Expected to alleviate treatment intensification concerns of the NIH Landmark Study

Advanced action decision for a treatment change is focused on the patient:
  • response to the ongoing treatment to reach personal BP target
  • relevant ongoing health changes
  • reduction/elimination of side-effects and potential adverse events
  • minimum number of drugs with maximum effect, safely

optima4BP wins the ONC Market R&D Challenge Award

optima4BP is currently undergoing a 60 patients randomized clinical trial, integrated into the care coordination flow at UCSF Medical Center.